Format
Sort by
Items per page

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 460

1.

Crebbp loss cooperates with Bcl2 over-expression to promote lymphoma in mice.

García-Ramírez I, Tadros S, González-Herrero I, Martín-Lorenzo A, Rodríguez-Hernández G, Moore D, Ruiz-Roca L, Blanco O, Alonso-López D, De Las Rivas J, Hartert K, Duval R, Klinkebiel D, Bast M, Vose J, Lunning M, Fu K, Greiner T, Rodrigues-Lima F, Jiménez R, García Criado FJ, García Cenador MB, Brindle P, Vicente-Dueñas C, Alizadeh A, Sánchez-García I, Green MR.

Blood. 2017 Mar 13. pii: blood-2016-08-733469. doi: 10.1182/blood-2016-08-733469. [Epub ahead of print]

PMID:
28288979
2.

NCCN Guidelines Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia, Version 1.2017.

Wierda WG, Zelenetz AD, Gordon LI, Abramson JS, Advani RH, Andreadis CB, Bartlett N, Byrd JC, Caimi P, Fayad LE, Fisher RI, Glenn MJ, Habermann TM, Harris NL, Hernandez-Ilizaliturri F, Hoppe RT, Horwitz SM, Kaminski MS, Kelsey CR, Kim YH, Krivacic S, LaCasce AS, Martin MG, Nademanee A, Porcu P, Press O, Rabinovitch R, Reddy N, Reid E, Roberts K, Saad AA, Snyder ED, Sokol L, Swinnen LJ, Vose JM, Yahalom J, Dwyer MA, Sundar H.

J Natl Compr Canc Netw. 2017 Mar;15(3):293-311.

PMID:
28275031
3.

Clinical Outcomes and 90-Day Costs Following Hemiarthroplasty or Total Hip Arthroplasty for Hip Fracture.

Nichols CI, Vose JG, Nunley RM.

J Arthroplasty. 2017 Jan 24. pii: S0883-5403(17)30055-4. doi: 10.1016/j.arth.2017.01.023. [Epub ahead of print]

4.

Angioimmunoblastic T-cell lymphoma: the many-faced lymphoma.

Lunning MA, Vose JM.

Blood. 2017 Mar 2;129(9):1095-1102. doi: 10.1182/blood-2016-09-692541. Epub 2017 Jan 23. Review.

PMID:
28115369
5.

Incidence of Bleeding-Related Complications During Primary Implantation and Replacement of Cardiac Implantable Electronic Devices.

Nichols CI, Vose JG.

J Am Heart Assoc. 2017 Jan 22;6(1). pii: e004263. doi: 10.1161/JAHA.116.004263.

6.

Inhibition of 4EBP phosphorylation mediates the cytotoxic effect of mTOR kinase inhibitors in aggressive B-cell lymphomas.

Bi C, Zhang X, Lu T, Zhang X, Wang X, Meng B, Zhang H, Wang P, Vose JM, Chan WC, McKeithan TW, Fu K.

Haematologica. 2017 Jan 19. pii: haematol.2016.159160. doi: 10.3324/haematol.2016.159160. [Epub ahead of print]

7.

The landscape of new drugs in lymphoma.

Younes A, Ansell S, Fowler N, Wilson W, de Vos S, Seymour J, Advani R, Forero A, Morschhauser F, Kersten MJ, Tobinai K, Zinzani PL, Zucca E, Abramson J, Vose J.

Nat Rev Clin Oncol. 2016 Dec 29. doi: 10.1038/nrclinonc.2016.205. [Epub ahead of print] Review.

PMID:
28031560
8.

Use of a saline-coupled bipolar sealer open liver resection for hepatic malignancy: Medical resource use and costs.

Nichols CI, Vose JG.

World J Gastroenterol. 2016 Dec 14;22(46):10189-10197. doi: 10.3748/wjg.v22.i46.10189.

9.

Venous thromboembolism in patients with hematologic malignancy and thrombocytopenia.

Khanal N, Bociek RG, Chen B, Vose JM, Armitage JO, Bierman PJ, Maness LJ, Lunning MA, Gundabolu K, Bhatt VR.

Am J Hematol. 2016 Nov;91(11):E468-E472. doi: 10.1002/ajh.24526. Epub 2016 Aug 29.

PMID:
27489982
10.

Addressing Administrative and Regulatory Burden in Cancer Clinical Trials: Summary of a Stakeholder Survey and Workshop Hosted by the American Society of Clinical Oncology and the Association of American Cancer Institutes.

Vose JM, Levit LA, Hurley P, Lee C, Thompson MA, Stewart T, Hofacker J, Bruinooge SS, Hayes DF.

J Clin Oncol. 2016 Sep 6. pii: JCO696781. [Epub ahead of print] No abstract available.

PMID:
27601549
11.

NCCN Guidelines Insights: Non-Hodgkin's Lymphomas, Version 3.2016.

Horwitz SM, Zelenetz AD, Gordon LI, Wierda WG, Abramson JS, Advani RH, Andreadis CB, Bartlett N, Byrd JC, Fayad LE, Fisher RI, Glenn MJ, Habermann TM, Lee Harris N, Hernandez-Ilizaliturri F, Hoppe RT, Kaminski MS, Kelsey CR, Kim YH, Krivacic S, LaCasce AS, Lunning M, Nademanee A, Press O, Rabinovitch R, Reddy N, Reid E, Roberts K, Saad AA, Sokol L, Swinnen LJ, Vose JM, Yahalom J, Zafar N, Dwyer M, Sundar H, Porcu P.

J Natl Compr Canc Netw. 2016 Sep;14(9):1067-79.

PMID:
27587620
12.

Sole rearrangement but not amplification of MYC is associated with a poor prognosis in patients with diffuse large B cell lymphoma and B cell lymphoma unclassifiable.

Landsburg DJ, Falkiewicz MK, Petrich AM, Chu BA, Behdad A, Li S, Medeiros LJ, Cassaday RD, Reddy NM, Bast MA, Vose JM, Kruczek KR, Smith SE, Patel P, Hernandez-Ilizaliturri F, Karmali R, Rajguru S, Yang DT, Maly JJ, Blum KA, Zhao W, Vanslambrouck C, Nabhan C.

Br J Haematol. 2016 Nov;175(4):631-640. doi: 10.1111/bjh.14282. Epub 2016 Jul 29.

13.

2016 ASCO Presidential Address: "Collective Wisdom: The Future of Patient-Centered Care and Research".

Vose JM.

J Clin Oncol. 2016 Sep 1;34(25):2945-9. doi: 10.1200/JCO.2016.68.9786. Epub 2016 Jul 11. No abstract available.

PMID:
27400938
14.

Combined copy number and mutation analysis identifies oncogenic pathways associated with transformation of follicular lymphoma.

Bouska A, Zhang W, Gong Q, Iqbal J, Scuto A, Vose J, Ludvigsen M, Fu K, Weisenburger DD, Greiner TC, Gascoyne RD, Rosenwald A, Ott G, Campo E, Rimsza LM, Delabie J, Jaffe ES, Braziel RM, Connors JM, Wu CI, Staudt LM, D'Amore F, McKeithan TW, Chan WC.

Leukemia. 2017 Jan;31(1):83-91. doi: 10.1038/leu.2016.175. Epub 2016 Jun 16.

15.

Survival of Subcutaneous Panniculitis-Like T-Cell Lymphoma and Peripheral T-Cell Lymphoma Not Otherwise Specified: A Propensity-Matched Analysis of the Surveillance, Epidemiology, and End Results Database.

Bhatt VR, Giri S, Verma V, Manandhar S, Pathak R, Bociek RG, Vose JM, Armitage JO.

Clin Lymphoma Myeloma Leuk. 2016 Jul;16(7):373-8. doi: 10.1016/j.clml.2016.04.015. Epub 2016 May 4.

PMID:
27349764
16.

Patient Comorbidity Status and Incremental Total Hospitalization Costs in Elective Orthopedic Procedures.

Nichols CI, Vose JG.

Orthopedics. 2016 Jul 1;39(4):237-46. doi: 10.3928/01477447-20160610-01. Epub 2016 Jun 20.

PMID:
27322174
17.

Forest drought as an emerging research priority.

Clark JS, Vose JM, Luce CH.

Glob Chang Biol. 2016 Jul;22(7):2317. doi: 10.1111/gcb.13252. No abstract available.

PMID:
27282321
18.

Pitfalls and major issues in the histologic diagnosis of peripheral T-cell lymphomas: results of the central review of 573 cases from the T-Cell Project, an international, cooperative study.

Bellei M, Sabattini E, Pesce EA, Ko YH, Kim WS, Cabrera ME, Martinez V, Dlouhy I, Paes RP, Barrese T, Vassallo J, Tarantino V, Vose J, Weisenburger D, Rüdiger T, Federico M, Pileri S.

Hematol Oncol. 2016 Jun 3. doi: 10.1002/hon.2316. [Epub ahead of print]

PMID:
27255982
19.

Updating the American Society of Clinical Oncology Value Framework: Revisions and Reflections in Response to Comments Received.

Schnipper LE, Davidson NE, Wollins DS, Blayney DW, Dicker AP, Ganz PA, Hoverman JR, Langdon R, Lyman GH, Meropol NJ, Mulvey T, Newcomer L, Peppercorn J, Polite B, Raghavan D, Rossi G, Saltz L, Schrag D, Smith TJ, Yu PP, Hudis CA, Vose JM, Schilsky RL.

J Clin Oncol. 2016 Aug 20;34(24):2925-34. doi: 10.1200/JCO.2016.68.2518. Epub 2016 May 31. No abstract available.

PMID:
27247218
20.

Clinical characteristics and outcomes of patients with Hodgkin lymphoma with central nervous system involvement: An international multicenter collaboration.

Cheah CY, Bröckelmann PJ, Chihara D, Moskowitz AJ, Engert A, Jerkeman M, El-Galaly TC, Augustson B, Vose J, Bartlett NL, Villa D, Connors JM, Feldman T, Pinnix CC, Milgrom SA, Dabaja B, Oki Y, Fanale MA.

Am J Hematol. 2016 Sep;91(9):894-9. doi: 10.1002/ajh.24429. Epub 2016 Jun 20.

PMID:
27222367

Supplemental Content

Loading ...
Support Center